A case of natalizumab ‐associated progressive multifocal leukoencephalopathy followed by immune reconstitution inflammatory syndrome with difficulty in the timing of immunotherapy

ConclusionsTreatment sequencing should be executed before the onset of NAT-PML. Changes in CSF cell count and IgG index may be useful for treatment decision; further research is needed.

Source: Clinical and Experimental Neuroimmunology - October 19, 2022 Category: Neurology Authors: Takamichi Sugimoto, Shuichiro Neshige, Shiro Aoki, Kazuhide Ochi, Ruoyi Ishikawa, Megumi Nonaka, Masahiro Nakamori, Tomohisa Nezu, Kazuo Nakamichi, Yu Yamazaki, Hirofumi Maruyama Tags: CASE REPORT Source Type: research